| 1 |
Age-Related Macular Degeneration: What Do We Know So Far? |
|
|
| Ho Hin Ma,Rasa Liutkeviciene |
|
| Acta medica Lituanica. 2021; 28(1): 7 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Intracellular amyloid-ß disrupts tight junctions of retinal pigment epithelium via NF-?B activation |
|
|
| Dong Hyun Jo,Chang Sik Cho,Jin Hyoung Kim,Jeong Hun Kim |
|
| Neurobiology of Aging. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye |
|
|
| Kuei-Ju Cheng,Chien-Ming Hsieh,Kunal Nepali,Jing-Ping Liou |
|
| Journal of Medicinal Chemistry. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Fundamental differences in patterns of retinal ageing between primates and mice |
|
|
| Jaimie Hoh Kam,Tobias W. Weinrich,Harpreet Shinhmar,Michael B. Powner,Nicholas W. Roberts,Asmaa Aboelnour,Glen Jeffery |
|
| Scientific Reports. 2019; 9(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules |
|
|
| Marcella Nebbioso,Alessandro Lambiase,Alberto Cerini,Paolo Giuseppe Limoli,Maurizio La Cava,Antonio Greco |
|
| International Journal of Molecular Sciences. 2019; 20(7): 1693 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Retinal pigment epithelial cells as a therapeutic tool and target against retinopathies |
|
|
| Barbara Pavan,Alessandro Dalpiaz |
|
| Drug Discovery Today. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
